promoter mutation

Relationship between core promoter mutation, clinical features and virus replication in HBV carriers

HBV核心启动子突变与临床表现及病毒复制的关系

Detection and analysis of core promoter mutation of hepatitis B virus

乙型肝炎病毒C基因启动子热点变异的检测及分析

Relationship between HBV c gene promoter gene mutation and serum HBV DNA contents in HCC

原发性肝癌患者乙型肝炎病毒C基因启动子变异与HBV dna关系的探讨

Previous study show that pol β promoter mutation may exist in many different forms of mutations and lead to its change of transcriptional activity in esophageal carcinoma.

先前本课题组研究发现人食管癌组织polβ基因启动子碱基序列存在不同形式突变且许多突变位点可引起其启动子转录活性的改变。

Clinical Significance of HBV Basal Core Promoter Double-nucleotide Mutation Detected by PCR-RFLP

PCR-RFLP分析HBV核心启动子基因突变的临床意义

Association of insulin promoter factor-1 gene mutation with the pathogenesis of diabetes in Shanghai

胰岛素启动子因子1基因突变与上海地区糖尿病发病的关联

Before interferon treatment, there were 10 cases of anti-IFN positive in core promoter mutation group, it has a significant difference than that in wild-type group with only 2 cases of anti-IFN positive ( P < 0.05).

在IFN治疗前，有BCP变异组抗IFN阳性10例，野生株组抗IFN阳性2例，两组相比，差异显著（P

Relationship between Shenzhen HBV genotype and precore/ core promoter mutation and antiviral effects

HBV基因型与前C/C启动子变异及抗病毒疗效的关系

Ets-1 interacted selectively with the~-1350GGAA~-1347 Ets element in the P21WAF1/ CIP1 promoter. Mutation of this element reduced basal and Ets-1-inducible P21WAF1/ CIP1 promoter-dependent expression.

Ets-1选择性地作用于P21WAF1/CIP1启动子中-1350GGAA-1347Ets元件，该元件的序列突变可降低基础表达和Ets-1诱导的P21WAF1/CIP1启动子依赖的表达。

Relationship between hepatitis B virus basic core promoter gene mutation and serum cytokines as well as liver lesion

乙型肝炎病毒核心基因启动子变异与细胞因子及肝损害的关系

It is probably for the core promoter mutation patients due to increase the production of anti-IFN antibody levels before interferon treatment, but no increase of the levels of anti-IFN after interferon treatment.

BCP变异的患者，在干扰素治疗前，有可能促进干扰素抗体的产生，但在干扰素治疗后，则不增加抗IFN的产生。

Study of ALK a promoter mutation in E. coli

关于E.coli中alk A基因启动子突变点的研究

Objective To investigate the relationship of HBV Lumivudine resistant and HBV genotypes and basic core promoter ( BCP) mutation.

目的了解拉米夫定耐药与HBV基因型及HBV基本核心启动子（BCP）突变之间的关系。

Relationship between Basal Core Promoter Combined Point Mutation of Hepatitis B Virus and TCM Syndrome Type

乙型肝炎病毒BCP联合点突变与中医证型的关系